858
Views
45
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Stroke in diabetic and non‐diabetic patients: Course and prognostic value of admission serum glucose

, , , &
Pages 357-364 | Received 27 Jan 2005, Accepted 11 Apr 2005, Published online: 08 Jul 2009

References

  • Kannel W. B., McGee D. L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120–6
  • Tuomilehto J., Rastenyte D., Jousilahti P., Sarti C., Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle‐aged Finnish population. Stroke 1996; 27: 210–5
  • Haheim L. L., Holme I., Hjermann I., Leren P. Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18‐year follow‐up of the Oslo Study. Stroke 1995; 26: 774–7
  • Hart C. L., Hole D. J., Smith G. D. Risk factors and 20‐year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke 1999; 30: 1999–2007
  • Olsson T., Viitanen M., Asplund K., Eriksson S., Hägg E. Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia 1990; 33: 244–9
  • Lithner F., Asplund K., Eriksson S., Hägg E., Strand T., Wester P. O. Clinical characteristics in diabetic stroke patients. Diabet Metab 1988; 14: 15–9
  • Woo J., Lam C. W. K., Kay R., Wong A. H. Y., Teoh R., Nicholls M. G. The influence of hyperglycemia and diabetes mellitus on immediate and 3‐month morbidity and mortality after acute stroke. Arch Neurol 1990; 47: 1174–7
  • Kiers L., Davis S. M., Larkins R., Hopper J., Tress B., Rossiter S. C., et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55: 263–70
  • Toni D., Sacchetti M. L., Argentino C., Gentile M., Cavalletti C., Frontoni M., et al. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients?. J Neurol 1992; 239: 382–6
  • Jorgensen H. S., Nakayama H., Raaschou H. O., Olsen T. S. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994; 25: 1977–84
  • Topic E., Pavlicek I., Brinar V., Korsic M. Glycosylated haemoglobin in clarification of the origin of hyperglycaemia in acute cerebrovascular accident. Diabet Med 1989; 6: 12–5
  • Megherbi S. E., Milan C., Minier D., Couvreur G., Osseby G. V., Tilling, , for the European BIOMED Study of Stroke Care Group, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from the European BIOMED Stroke Project. Stroke 2003; 34: 688–94
  • Capes S. E., Hunt D., Malmberg K., Pathak P., Gerstein H. C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. A systematic overview. Stroke 2001; 32: 2426–32
  • Williams L. S., Rotich J., Qi R., Fineberg N., Espay A., Bruno A., et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59: 67–71
  • Slany J., Lenzhofer R., Kaiser R., Exner I., Schmid W., Hügel H., , für die Arbeitsgemeinschaft internistisches Insultregister, et al. Insultbehandlung an internen Abteilungen. Eine österreichische Multizenterstudie. Dtsch Med Wochenschr 2002; 127: 1575–80
  • Mahoney F. I., Barthel D. W. Functional evaluation: The Barthel Index. Maryland State Med J 1965; 14: 61–5
  • van Swieten J. C., Koudstaal P. J., Visser M. C., Schouten H. J. A., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–7
  • Brott T., Adams H. P Jr., Olinger C. P., Marler J. R., Barsan W. G., Biller J., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864–70
  • Karapanayiotides T. h., Piechowski‐Jozwiak B., van Melle G., Bogousslavsky J., Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 2004; 62: 1558–62
  • Steiner M. M., Brainin M. Austrian Stroke Registry for Acute Stroke Units. The quality of acute stroke units on a nation‐wide level: the Austrian Stroke Registry for acute stroke units. Eur J Neurol 2003; 10: 353–60
  • Rodriguez B. L., D'Agostino R., Abbott R. D., Kagan A., Burchfiel C. M., Yano K., et al. Risk of hospitalised stroke in men enrolled in the Honolulu Heart Program and the Framingham Study. A comparison of incidence and risk factor effects. Stroke 2002; 33: 230–7
  • Alex M., Baron E. K., Goldenberg S., Blumenthal H. T. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation 1962; 25: 663–73
  • McCuskey P. A., McCuskey R. S. In vivo and electron microscopic study of the development of cerebral diabetic microangiography. Microcirc Endothelium Lymphatics 1984; 1: 221–44
  • Powell H. C., Rosoff J., Myers R. R. Microangiopathy in human diabetic neuropathy. Acta Neuropathol (Berl) 1985; 68: 295–305
  • Alvarez‐Sabin J., Molina C. A., Montaner J., Arenillas J. F., Huertas R., Ribo M., et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator‐treated patients. Stroke 2003; 34: 1235–41
  • Baird T. A., Parsons M. W., Phanh T., Butcher K. S., Desmond P. M., Tress B. M., et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208–14
  • Bruno A., Biller J., Adams H. P Jr., Clarke W. R., Woolson R. F., Williams L. S., , for the Trial of ORG in Acute Stroke Treatment (TOAST) Investigators, et al. Acute blood glucose level and outcome from ischemic stroke. Neurology 1999; 52: 280–4
  • Weir C. J., Murray G. D., Dyker A. G., Lees K. R. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 1997; 314: 1303–6
  • Anderson R. E., Tan W. K., Martin H. S., Meyer F. B. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999; 30: 160–70
  • Coutinho M., Wang Y., Gerstein H. C., Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233–40
  • Hamilton M. G., Tranmer B. I., Auer R. N. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995; 82: 262–8
  • Scott J. F., Robinson G. M., French J. M., O'Connell J. E., Alberti K. G. M. M., Gray C. S. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia. The Glucose Insulin in Stroke Trial (GIST). Stroke 1999; 30: 793–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.